Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 472

1.

Multiple Score Comparison: a network meta-analysis approach to comparison and external validation of prognostic scores.

Haile SR, Guerra B, Soriano JB, Puhan MA; 3CIA collaboration.

BMC Med Res Methodol. 2017 Dec 21;17(1):172. doi: 10.1186/s12874-017-0433-2.

2.

The role of beta-blockers in the management of chronic obstructive pulmonary disease.

Leitao Filho FS, Alotaibi NM, Yamasaki K, Ngan DA, Sin DD.

Expert Rev Respir Med. 2018 Feb;12(2):125-135. doi: 10.1080/17476348.2018.1419869. Epub 2017 Dec 27.

PMID:
29258360
3.

Reply.

Leitao Filho FS, Ra SW, Mattman A, Schellenberg RS, Sin DD.

J Allergy Clin Immunol. 2017 Dec 5. pii: S0091-6749(17)31670-6. doi: 10.1016/j.jaci.2017.10.013. [Epub ahead of print] No abstract available.

PMID:
29221816
4.

Lung tissue gene-expression signature for the ageing lung in COPD.

de Vries M, Faiz A, Woldhuis RR, Postma DS, de Jong TV, Sin DD, Bossé Y, Nickle DC, Guryev V, Timens W, van den Berge M, Brandsma CA.

Thorax. 2017 Dec 6. pii: thoraxjnl-2017-210074. doi: 10.1136/thoraxjnl-2017-210074. [Epub ahead of print]

PMID:
29212667
5.

Surfactant protein D is a causal risk factor for COPD: results of Mendelian randomisation.

Obeidat M, Li X, Burgess S, Zhou G, Fishbane N, Hansel NN, Bossé Y, Joubert P, Hao K, Nickle DC, van den Berge M, Timens W, Cho MH, Hobbs BD, de Jong K, Boezen M, Hung RJ, Rafaels N, Mathias R, Ruczinski I, Beaty TH, Barnes KC, Paré PD, Sin DD; International COPD Genetics Consortium, Lung eQTL Consortium, Lung Health Study.

Eur Respir J. 2017 Nov 30;50(5). pii: 1700657. doi: 10.1183/13993003.00657-2017. Print 2017 Nov.

PMID:
29191953
6.

Multiple reaction monitoring mass spectrometry to identify novel plasma protein biomarkers of treatment response in cystic fibrosis pulmonary exacerbations.

Roberts JM, Dai DLY, Hollander Z, Ng RT, Tebbutt SJ, Wilcox PG, Sin DD, Quon BS.

J Cyst Fibros. 2017 Nov 21. pii: S1569-1993(17)30950-5. doi: 10.1016/j.jcf.2017.10.013. [Epub ahead of print]

PMID:
29174082
7.

A simple algorithm for the identification of clinical COPD phenotypes.

Burgel PR, Paillasseur JL, Janssens W, Piquet J, Ter Riet G, Garcia-Aymerich J, Cosio B, Bakke P, Puhan MA, Langhammer A, Alfageme I, Almagro P, Ancochea J, Celli BR, Casanova C, de-Torres JP, Decramer M, Echazarreta A, Esteban C, Gomez Punter RM, Han MK, Johannessen A, Kaiser B, Lamprecht B, Lange P, Leivseth L, Marin JM, Martin F, Martinez-Camblor P, Miravitlles M, Oga T, Sofia Ramírez A, Sin DD, Sobradillo P, Soler-Cataluña JJ, Turner AM, Verdu Rivera FJ, Soriano JB, Roche N; Initiatives BPCO, EABPCO, Leuven and 3CIA study groups.

Eur Respir J. 2017 Nov 2;50(5). pii: 1701034. doi: 10.1183/13993003.01034-2017. Print 2017 Nov.

PMID:
29097431
8.

Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.

Allen RJ, Porte J, Braybrooke R, Flores C, Fingerlin TE, Oldham JM, Guillen-Guio B, Ma SF, Okamoto T, John AE, Obeidat M, Yang IV, Henry A, Hubbard RB, Navaratnam V, Saini G, Thompson N, Booth HL, Hart SP, Hill MR, Hirani N, Maher TM, McAnulty RJ, Millar AB, Molyneaux PL, Parfrey H, Rassl DM, Whyte MKB, Fahy WA, Marshall RP, Oballa E, Bossé Y, Nickle DC, Sin DD, Timens W, Shrine N, Sayers I, Hall IP, Noth I, Schwartz DA, Tobin MD, Wain LV, Jenkins RG.

Lancet Respir Med. 2017 Nov;5(11):869-880. doi: 10.1016/S2213-2600(17)30387-9. Epub 2017 Oct 20.

9.

Serum bilirubin and the risk of chronic obstructive pulmonary disease exacerbations.

Brown KE, Sin DD, Voelker H, Connett JE, Niewoehner DE, Kunisaki KM; COPD Clinical Research Network.

Respir Res. 2017 Oct 24;18(1):179. doi: 10.1186/s12931-017-0664-0.

10.

Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.

Tammemagi MC, Schmidt H, Martel S, McWilliams A, Goffin JR, Johnston MR, Nicholas G, Tremblay A, Bhatia R, Liu G, Soghrati K, Yasufuku K, Hwang DM, Laberge F, Gingras M, Pasian S, Couture C, Mayo JR, Nasute Fauerbach PV, Atkar-Khattra S, Peacock SJ, Cressman S, Ionescu D, English JC, Finley RJ, Yee J, Puksa S, Stewart L, Tsai S, Haider E, Boylan C, Cutz JC, Manos D, Xu Z, Goss GD, Seely JM, Amjadi K, Sekhon HS, Burrowes P, MacEachern P, Urbanski S, Sin DD, Tan WC, Leighl NB, Shepherd FA, Evans WK, Tsao MS, Lam S; PanCan Study Team.

Lancet Oncol. 2017 Nov;18(11):1523-1531. doi: 10.1016/S1470-2045(17)30597-1. Epub 2017 Oct 18.

PMID:
29055736
11.

Survival of Lung Transplant Candidates with COPD: BODE Score Reconsidered.

Reed RM, Cabral HJ, Dransfield MT, Eberlein M, Merlo CA, Mulligan MJ, Netzer G, Sanchez PG, Scharf SM, Sin DD, Celli BR.

Chest. 2017 Oct 17. pii: S0012-3692(17)32900-8. doi: 10.1016/j.chest.2017.10.008. [Epub ahead of print]

PMID:
29054348
12.

A Potent Tartrate Resistant Acid Phosphatase Inhibitor to Study the Function of TRAP in Alveolar Macrophages.

Boorsma CE, van der Veen TA, Putri KSS, de Almeida A, Draijer C, Mauad T, Fejer G, Brandsma CA, van den Berge M, Bossé Y, Sin D, Hao K, Reithmeier A, Andersson G, Olinga P, Timens W, Casini A, Melgert BN.

Sci Rep. 2017 Oct 3;7(1):12570. doi: 10.1038/s41598-017-12623-w.

13.

Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets.

Leung JM, Sin DD.

BMJ. 2017 Sep 25;358:j3772. doi: 10.1136/bmj.j3772. Review.

PMID:
28947632
14.

Work productivity loss in mild to moderate COPD: lessons learned from the CanCOLD study.

de Sousa Sena R, Ahmed S, Tan WC, Li PZ, Labonté L, Aaron SD, Benedetti A, Chapman KR, Walker B, Fitzgerald JM, Hernandez P, Maltais F, Marciniuk DD, O'Donnell DE, Sin DD, Bourbeau J; CanCOLD Collaborative Research Group and The Canadian Respiratory Research Network.

Eur Respir J. 2017 Sep 12;50(3). pii: 1701154. doi: 10.1183/13993003.01154-2017. Print 2017 Sep. No abstract available.

PMID:
28899939
15.

Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study.

Kirby M, Tanabe N, Tan WC, Zhou G, Obeidat M, Hague CJ, Leipsic J, Bourbeau J, Sin DD, Hogg JC, Coxson HO; CanCOLD Collaborative Research Group; Canadian Respiratory Research Network; CanCOLD Collaborative Research Group, the Canadian Respiratory Research Network.

Am J Respir Crit Care Med. 2018 Jan 1;197(1):56-65. doi: 10.1164/rccm.201704-0692OC.

PMID:
28886252
16.

GOLD 2017 Classification and Lung Function Decline in Chronic Obstructive Pulmonary Disease.

Tan WC, Bourbeau J, Aaron SD, Zhou G, Maltais F, Hernandez P, Fitzgerald JM, Marciniuk DD, Walker BL, Sin DD.

Am J Respir Crit Care Med. 2017 Aug 31. doi: 10.1164/rccm.201706-1154LE. [Epub ahead of print] No abstract available.

PMID:
28858570
17.

A Novel Method of Estimating Small Airway Disease Using Inspiratory-to-Expiratory Computed Tomography.

Kirby M, Yin Y, Tschirren J, Tan WC, Leipsic J, Hague CJ, Bourbeau J, Sin DD, Hogg JC, Coxson HO; CanCOLD Collaborative Research Group and the Canadian Respiratory Research Network.

Respiration. 2017;94(4):336-345. doi: 10.1159/000478865. Epub 2017 Aug 23.

PMID:
28848199
18.

GDF11: a fountain of youth for the ageing COPD lung?

Obeidat M, Sin DD.

Thorax. 2017 Oct;72(10):874-875. doi: 10.1136/thoraxjnl-2017-210359. Epub 2017 Aug 11. No abstract available.

PMID:
28802278
19.

Concern of underdiagnosing asthma-COPD overlap syndrome if age limit of 40 years for asthma is used.

Sin DD, Leung JM, Wechsler ME.

Eur Respir J. 2017 Aug 3;50(2). pii: 1701120. doi: 10.1183/13993003.01120-2017. Print 2017 Aug. No abstract available.

20.

Excess economic burden of comorbidities in COPD: a 15-year population-based study.

Chen W, FitzGerald JM, Sin DD, Sadatsafavi M; Canadian Respiratory Research Network.

Eur Respir J. 2017 Jul 27;50(1). pii: 1700393. doi: 10.1183/13993003.00393-2017. Print 2017 Jul.

PMID:
28751416

Supplemental Content

Loading ...
Support Center